Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05009251 · ClinicalTrials.gov registry record · NA
Using Explainable AI Risk Predictions to Nudge Influenza Vaccine Uptake
A NA study, sponsored by National Bureau of Economic Research.
- Completed
- Registry status
- NA
- Development phase
- 45,061
- Enrollment target
NCT05009251: Completed NA study, sponsored by National Bureau of Economic Research.
NCT05009251 is a NA study that has completed, run by National Bureau of Economic Research. The registered enrollment target is 45,061 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (3112% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05009251, a NA study, has completed, sponsored by National Bureau of Economic Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 45,061 participants
- Enrollment target
Study Summary
The study team previously demonstrated that patients are more likely to receive flu vaccine after learning that they are at high risk for flu complications. Building on this past work, the present study will explore whether providing reasons that patients are considered high risk for flu complications (a) further increases the likelihood they will receive flu vaccine and (b) decreases the likelihood that they receive diagnoses of flu and/or flu-like symptoms in the ensuing flu season. It will also examine whether informing patients that their high-risk status was determined by analyzing their medical records or by an artificial intelligence (AI) / machine-learning (ML) algorithm analyzing their medical records will affect the likelihood of receiving the flu vaccine or diagnoses of flu and/or flu-like symptoms.
Primary Outcome
Received flu vaccination
Interventions
- BEHAVIORAL Reminder
- BEHAVIORAL Risk reduction
- BEHAVIORAL Medical records-based recommendation
- BEHAVIORAL Algorithm-based recommendation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45,061 participants |
| Start Date | 2021-09-09 |
| Est. Completion | 2022-07-31 |
| Phase | NA |
What the finished NCT05009251 record still lists
NCT05009251 is an interventional study that assigns participants to a tested intervention. Its 45,061 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (3112% higher).
The record links to 0 conditions, and to 4 interventions - of which Reminder is the first listed.
NCT05009251 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05009251 about?
NCT05009251 is a clinical study titled "Using Explainable AI Risk Predictions to Nudge Influenza Vaccine Uptake". The study team previously demonstrated that patients are more likely to receive flu vaccine after learning that they are at high risk for flu complications. Building on this past work, the present study will explore whether providing reasons that patients are considered high risk for flu complicatio...
What is the current status of trial NCT05009251?
This trial is currently completed. It is a NA study. The enrollment target is 45,061 participants. The study started on 2021-09-09. Estimated completion is 2022-07-31.
What interventions are being tested in trial NCT05009251?
The interventions under investigation include: Reminder (BEHAVIORAL), Risk reduction (BEHAVIORAL), Medical records-based recommendation (BEHAVIORAL), Algorithm-based recommendation (BEHAVIORAL).
Who is sponsoring clinical trial NCT05009251?
This trial is sponsored by National Bureau of Economic Research, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05009251's enrollment target sits among peer trials
45,061 7th of 2000 higher than 1,994 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05607732 · 45,257 participants · NA
Primary Care Detection of Cognitive Impairment Leveraging Health & Consumer Technologies in Underserved Communities: The MyCog Trial
- NCT06824350 · 45,450 participants · NA
Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates
- NCT06597968 · 45,991 participants
Evaluating the Real World Performance of an AI Based Lung Nodule Detection Tool
- NCT03977402 · 47,500 participants
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI